Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characteristics of Patients With Autoimmune Interstitial Lund Disease From Argentina

NCT05365009 is registered in ClinicalTrials.gov with EPIMAR registry as lead sponsor.

NCT NCT05365009
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05365009 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characteristics of Patients With Autoimmune Interstitial Lund Disease From Argentina
Lead sponsor
EPIMAR registry
Phase
Observational
Overall status
Recruiting
Start date
April 10, 2022
Completion date
October 31, 2027
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

interstitial lung disease due to systemic disease